91Â鶹ÌìÃÀ

Advancing Microbial Science for a Healthier World

The 91Â鶹ÌìÃÀ Health Meeting is a dynamic, inclusive scientific ecosystem that brings together professionals from across the clinical, public health, biomedical and translational research spectrum to tackle urgent challenges at the intersection of microbial science and human health. By combining the Antimicrobial Agents and Resistance (AAR), Clinical and Public Health Microbiology (CPHM) and Clinical Infections and Vaccines (CIV) communities, this new meeting fosters a holistic, multi-disciplinary approach to understanding infectious diseases, innovating diagnostics and treatment, and strengthening global health resilience.

With a commitment to advancing microbial science for societal benefit, and a focus on diagnostics, prevention, therapeutics, surveillance and the microbiome, the 91Â鶹ÌìÃÀ Health Meeting facilitates cross-cutting dialogue among academic, clinical, public health and industry sectors.

Early abstract submission now open!

Key Focus Areas

• Diagnostics and Laboratory Systems: explore diagnostic microbiology and clinical lab operations that improve the speed, accuracy and equity of infectious disease detection, including molecular diagnostics, automation, AI, stewardship and decentralized testing for clinical and public health use.
• Vaccines, Immunology and Prevention: delve into novel vaccine technologies, immunological profiling and prevention strategies for infectious diseases in humans and animals, including translational immunology, innovative platforms (e.g., mRNA, vector-based), population-level prevention and immune-based diagnostics.
• Antimicrobials and Therapeutics: advance discovery, development and application of antimicrobial and non-traditional therapies, including mechanisms of action, resistance, pharmacodynamics and emerging treatments (e.g., phages and peptides). This area also explores other innovative solutions for antimicrobial resistance, tolerance and toxicity.
• Clinical Infectious Disease and Management: apply diagnosis, treatment and clinical management of infectious diseases across patient populations and health care settings, including adult and pediatric care, infections in immunocompromised patients, global disease patterns and hospital acquired infections, with an emphasis on evidence-based practice to improve patient outcomes.
• Public Health, Surveillance and Systems: use microbial surveillance systems, including genomic and environmental surveillance, AMR tracking and real-time outbreak response, to generate actionable insights to prevent, detect and respond to infectious disease threats across human, animal and environmental health.
• Microbiomes and Ecosystems Health: explore functions, interactions and therapeutic potential of microbiomes across humans, animals, plants and the environment, integrating systems of biology and engineered interventions to advance applications in health, agriculture and climate resilience. 

Advancing Innovation at the Intersection of Microbial Science and Global Health

From emerging pathogens and microbiome-driven therapeutics to next-generation surveillance and prevention strategies, these featured sessions spotlight groundbreaking science shaping the future of human and animal health.

• Hot Off the Bench: Research From Trainees in Clinical Microbiology.
• Progress in the Development of Antimicrobials Against ESKAPE Pathogens.
• Model Systems for Novel Antifungals: Moving Away From Mice.

Join experts, innovators and practitioners as they share insights that are redefining diagnostics, treatment and global health resilience.

Kelli Maddock, DrPH

North Dakota State University
Fargo, N.D.

Matt Robinson, M.D.

Johns Hopkins School of Medicine
Baltimore